PAVmed Subsidiary Lucid Diagnostics Announces Commercial Launch of EsoGuard Esophageal DNA Test Dec 19, 2019 9:30am EST
PAVmed Reports Third Quarter 2019 Financial Results and Provides Business Update Nov 21, 2019 4:00pm EST
PAVmed Partners with Laser Technology Pioneer Dr. Jacob Wong to Develop and Commercialize Non-Invasive Laser-based Diagnostic Products Nov 14, 2019 9:30am EST
PAVmed Secures Financing up to $14 Million for Advancement of its Lead Products to Commercialization Nov 05, 2019 7:00am EST
PAVmed Reports Second Quarter 2019 Financial Results and Provides Business Update Sep 05, 2019 9:30am EDT
PAVmed Successfully Completes Clinical Safety Study Procedures for CarpX™ 510(k) Re-submission Aug 15, 2019 9:30am EDT
